INC Research Holdings Inc (INCR) Receives $49.63 Consensus Price Target from Brokerages

Shares of INC Research Holdings Inc (NASDAQ:INCR) have earned an average rating of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $49.88.

A number of brokerages recently weighed in on INCR. BidaskClub upgraded shares of INC Research from a “sell” rating to a “hold” rating in a report on Thursday, December 7th. SunTrust Banks reduced their target price on shares of INC Research to $50.00 and set a “buy” rating for the company in a report on Friday, December 1st. Jefferies Group upgraded shares of INC Research from a “hold” rating to a “buy” rating and raised their target price for the stock from $62.50 to $69.00 in a report on Monday, October 9th. Mizuho began coverage on shares of INC Research in a report on Thursday, September 21st. They set a “neutral” rating and a $57.00 target price for the company. Finally, Credit Suisse Group reduced their target price on shares of INC Research from $68.00 to $54.00 and set an “outperform” rating for the company in a report on Tuesday, November 14th.

INC Research (INCR) traded down $0.80 during trading on Monday, hitting $40.50. 1,480,000 shares of the stock traded hands, compared to its average volume of 1,380,000. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.99. The company has a market capitalization of $4,230.00, a PE ratio of -71.05, a PEG ratio of 1.27 and a beta of 1.09. INC Research has a twelve month low of $33.60 and a twelve month high of $61.10.

INC Research (NASDAQ:INCR) last issued its earnings results on Thursday, November 9th. The company reported $0.54 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.09). The business had revenue of $592.21 million for the quarter, compared to the consensus estimate of $604.95 million. INC Research had a positive return on equity of 14.42% and a negative net margin of 4.29%. The company’s quarterly revenue was up 128.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.64 earnings per share. equities research analysts forecast that INC Research will post 2.15 earnings per share for the current year.

Several large investors have recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of INC Research by 14.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock valued at $103,000 after acquiring an additional 228 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of INC Research by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock valued at $139,000 after acquiring an additional 356 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in shares of INC Research by 4.9% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 20,946 shares of the company’s stock valued at $1,095,000 after acquiring an additional 986 shares in the last quarter. Comerica Bank lifted its position in shares of INC Research by 3.1% in the 3rd quarter. Comerica Bank now owns 43,790 shares of the company’s stock valued at $2,483,000 after acquiring an additional 1,331 shares in the last quarter. Finally, Strs Ohio lifted its position in shares of INC Research by 5.6% in the 3rd quarter. Strs Ohio now owns 26,600 shares of the company’s stock valued at $1,391,000 after acquiring an additional 1,400 shares in the last quarter. Institutional investors and hedge funds own 99.50% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was first posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.thelincolnianonline.com/2018/01/13/inc-research-holdings-inc-incr-receives-49-63-consensus-price-target-from-brokerages-updated.html.

About INC Research

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Analyst Recommendations for INC Research (NASDAQ:INCR)

Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply